Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

Clinical trial NCT07729397 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07729397
Sponsor: The Methodist Hospital Research Institute
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B-Cell Lymphoma (DLBCL)Hodgkin Lymphoma Peripheral T-cell Lymphoma (PTCL)Anaplastic Large Cell Lymphoma, ALK-Positive Anaplastic Large Cell Lymphoma, ALK-Negative

Start date: 2027-01-15
Primary completion: 2030-03-31
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.